High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study

Affiliations

• ¹ Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
• ² Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
• ³ Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
• ⁴ Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
• ⁵ Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
• ⁶ Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
• ⁷ Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
• ⁸ Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
• ⁹ Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
• ¹⁰ Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
• ¹¹ Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan.
• ¹² Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
• ¹³ Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
• ¹⁴ Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
• ¹⁵ Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
• ¹⁶ Kanazawa University, Kanazawa, Japan.
• ¹⁷ Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ¹⁸ Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.